Cargando…
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The fear of acquiring infection and spreading to vulnerable people has severely impacted society’s socio-economic status. To put an...
Autores principales: | Jain, Swati, Batra, Himanshu, Yadav, Poonam, Chand, Subhash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711779/ https://www.ncbi.nlm.nih.gov/pubmed/33153096 http://dx.doi.org/10.3390/vaccines8040649 |
Ejemplares similares
-
Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
por: Taslem Mourosi, Jarin, et al.
Publicado: (2022) -
Bioinformatics in Design of Antiviral Vaccines
por: Nandy, Ashesh, et al.
Publicado: (2019) -
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
por: Lopes, Alessandra, et al.
Publicado: (2019) -
Antiviral Immunity and Virus Vaccines
Publicado: (2017) -
Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
por: Jacobson, Kenneth A., et al.
Publicado: (2019)